Try it
Pharmacology · Autonomic: LABA monotherapy
Sample itemA 28-year-old with persistent asthma has been using only salmeterol inhaler for months. What is the main concern with this regimen?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Increased risk of severe exacerbations and asthma-related death without an inhaled corticosteroid
Long-acting beta agonists treat symptoms but not airway inflammation, and monotherapy is associated with increased severe events. They must always be combined with an inhaled corticosteroid in asthma.
Option by option
A. Rapid development of adrenal suppression
Adrenal suppression is related to steroids, not LABAs.
B. Loss of bronchodilator action within hours
Salmeterol has a duration of about 12 hours.
C. Paradoxical bradycardia
Tachycardia, not bradycardia, is typical.
D. Increased risk of severe exacerbations and asthma-related death without an inhaled corticosteroid (correct)
Correct. LABA alone leaves inflammation untreated and raises serious risk.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?